Cryptococcal Lung Infections.

Link to article at PubMed

Related Articles

Cryptococcal Lung Infections.

Clin Chest Med. 2017 Sep;38(3):451-464

Authors: Skolnik K, Huston S, Mody CH

Abstract
Cryptococcus is among the most common invasive fungal pathogens globally and is one of the leading causes of acquired immunodeficiency virus-related deaths. Cryptococcus neoformans and Cryptococcus gattii are the most clinically relevant species and account for most cryptococcal disease. Pulmonary manifestations can range from mild symptoms to life-threatening infection. Treatment is tailored based on the severity of pulmonary infection, the presence of disseminated or central nervous system disease, and patient immune status. Amphotericin B and flucytosine followed by fluconazole remain the standard agents for the treatment of severe cryptococcal infection.

PMID: 28797488 [PubMed - in process]

Leave a Reply

Your email address will not be published.